Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 3,114 | 3,665 | 3,096 | 3,110 | 2,421 |
| Gross Profit | 3,114 | 3,665 | 3,096 | 3,110 | 2,421 |
| Operating Expenses | 8,725 | 7,705 | 7,846 | 8,832 | 9,309 |
| Operating Income | -5,611 | -4,040 | -4,750 | -5,722 | -6,888 |
| Other Income | -2,264 | -2,557 | -2,327 | -2,342 | -782 |
| Pre-tax Income | -7,875 | -6,597 | -7,077 | -8,064 | -7,670 |
| Net Income Continuous | -7,875 | -6,597 | -7,077 | -8,064 | -7,670 |
| Net Income Discontinuous | 178 | 325 | 80 | 132 | 414 |
| Net Income | $-7,697 | $-6,272 | $-6,997 | $-7,932 | $-7,256 |
| EPS Basic Total Ops | -68.28 | -55.07 | -63.00 | -77.09 | -72.25 |
| EPS Basic Continuous Ops | -70.04 | -57.84 | -63.73 | -78.30 | -76.48 |
| EPS Basic Discontinuous Ops | 1.59 | 2.81 | 0.72 | 1.28 | 4.13 |
| EPS Diluted Total Ops | -68.28 | -55.07 | -63.00 | -77.09 | -72.25 |
| EPS Diluted Continuous Ops | -70.04 | -57.84 | -63.73 | -78.30 | -76.48 |
| EPS Diluted Discontinuous Ops | 1.59 | 2.81 | 0.72 | 1.28 | 4.13 |
| EBITDA(a) | $-5,369 | $-3,784 | $-4,455 | $-5,423 | $-6,594 |